Delivery Order SPE2DB20D2104-SPE2DB24FR01Z
- Not listed
- This federal contract award, valued at $13,339.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of Doxepin HCL 6 mg tablets, a medication used to treat mental...
- This federal contract award, valued at $10,367.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Doxepin HCL 3 mg tablets in quantities of 30s. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves...
- This is a Delivery Order contract valued at $14,828.37, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Doxepin HCL 3 mg tablets, a mental health medication, to support federal healthcare programs. This award is a task order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,430.46 firm fixed-price delivery order is for the supply of Doxepin HCL 3 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of December 26, 2023 and was awarded on December 22, 2023 with no set-aside designation,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of doxepin hydrochloride 3 mg tablets, a medication used to treat certain mental health conditions. The contract has a firm fixed price of $11,201.31 and an ultimate completion date of November 1, 2023. This delivery order is part of a larger Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Doxepin HCL 6 mg tablets, a medication used to treat mental health conditions. The contract has a total ceiling value of $5,189.06 and runs through May 14, 2024. It is a firm fixed price contract with no set-aside designation, indicating open competition....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to provide Doxepin HCL 3 mg tablets. The contract has a ceiling value of $2,467.05 and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and has no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
- This is a federal contract award valued at $3,939.01 from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Doxepin HCL 3 mg tablets, a generic medication. The contract is a firm fixed-price delivery order with an ultimate completion date of October 31, 2023. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,225.68 delivery order contract is for the supply of Doxepin HCL 3 mg tablets, with a completion date of December 21, 2023. The contract is not designated as a set-aside and is a firm fixed-price delivery order. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of 3mg doxepin hydrochloride tablets to the Defense Logistics Agency (DLA), a defense agency. The $1,057.62 fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR01ZDelivery Order
This federal contract award, valued at $2,079.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Doxepin HCL 3 mg tablets, a medication used to treat various mental health conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/2/23 |